A new study has created a highly selective inhibitor for Matrix Metallopeptidase 7 (MMP7), an enzyme important for cancer spread and progression. Using advanced peptide discovery technology ...

and the University of Tokyo has made a significant breakthrough in the fight against cancer by developing a highly selective inhibitor for an enzyme called Matrix Metallopeptidase 7 (MMP7).

1). In COPD and BPD models, AB1000 reduced key pro-inflammatory markers such as matrix metallopeptidase 9 (MMP-9), C-reactive protein (CRP), and interleukin 1 beta (IL-1β), and increased anti ...

Thus, long before we were able to develop useful specific inhibitors of ACE, Miguel Ondetti and I had formulated a hypothetical working model of ACE as a zinc metallopeptidase with a catalytic ...

and the University of Tokyo has made a significant breakthrough in the fight against cancer by developing a highly selective inhibitor for an enzyme called Matrix Metallopeptidase 7 (MMP7).